Skip to main content

Print Bookmark

Press Releases & Company News

Download the PDF version: EN | DE | IT

Digestive & Liver Disease journal published an article on Low Molecular Weight Heparin MMX

Digestive & Liver Disease, a journal of the Elsevier Group, in its September 2007 issue, published the article: Safety and Efficacy of Oral, Colonic-Release low molecular weight Heparin MMX™ for the treatment of mild to moderate left sided Ulcerative Colitis: a preliminary report for a pilot study.

Contacts
For further information, please contact:
Dr. Chris Tanner, CFO
Cosmo Pharmaceuticals
Via C. Colombo 1 1 - 20020 Lainate, Italy
Tel: +39 02 9333 7614

Get adobe reader

Most computers will open PDF documents automatically, but you may need to download Adobe Reader.